A detailed history of Black Rock Inc. transactions in Nanobiotix S.A. stock. As of the latest transaction made, Black Rock Inc. holds 239,008 shares of NBTX stock, worth $972,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares
239,008
Previous 253,454 5.7%
Holding current value
$972,762
Previous $1.65 Million 27.44%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.16 - $7.31 $60,095 - $105,600
-14,446 Reduced 5.7%
239,008 $1.2 Million
Q1 2024

May 10, 2024

BUY
$6.12 - $8.13 $213,826 - $284,054
34,939 Added 15.99%
253,454 $1.65 Million
Q4 2023

Feb 13, 2024

BUY
$5.34 - $9.19 $1.17 Million - $2.01 Million
218,515 New
218,515 $1.59 Million

Others Institutions Holding NBTX

About Nanobiotix S.A.


  • Ticker NBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,875,900
  • Market Cap $142M
  • Description
  • Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...
More about NBTX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.